Shanté is a Research Scientist who joined SXT in 2017 and serves as a Drug Inhibition and Drug Metabolism Study Director and Drug Transport Lead Scientist for multiple nonclinical, drug interaction-related contract studies. So let’s get to know more about her!
Four Ways CROs Drive Innovation for Improved In Vitro Drug Metabolism and Pharmacokinetics (DMPK) Studies
Agility and focused growth allow drug developers to outsource expertise and benefit the industry at-large by fostering innovation. Panelists at the 2021 Annual DMDG Meeting…
Moving a new drug from lab to market is difficult, time-consuming and expensive for any size pharmaceutical or biotechnology company....
Subscribe to our Newsletter
Stay up to date with our news, events and research
Do you have a question or a request for upcoming blog content?
We love to get your feedback